Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).
about
Gesture Performance in Schizophrenia Predicts Functional Outcome After 6 Months.Nonverbal social communication and gesture control in schizophreniaMethodological issues in negative symptom trialsToward the next generation of negative symptom assessments: the collaboration to advance negative symptom assessment in schizophrenia.The Longitudinal Course of Gross Motor Activity in Schizophrenia - Within and between Episodes.Negative expectancy appraisals and defeatist performance beliefs and negative symptoms of schizophrenia.Development and psychometric validation of the Clinical Assessment Interview for Negative Symptoms (CAINS).Efficacy and safety of oxytocin augmentation therapy for schizophrenia: an updated systematic review and meta-analysis of randomized, placebo-controlled trials.A randomized pilot study of MOtiVation and Enhancement (MOVE) Training for negative symptoms in schizophrenia.The brief negative symptom scale: validation of the German translation and convergent validity with self-rated anhedonia and observer-rated apathy.Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptomsMeasuring negative symptoms in patients with schizophrenia: reliability and validity of the Korean version of the Motivation and Pleasure Scale-Self-ReportSleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosisPhysical activity level and medial temporal health in youth at ultra high-risk for psychosisFrom perception to functional outcome in schizophrenia: modeling the role of ability and motivation.The negative symptoms of schizophrenia: category or continuum?Neurocognition and neuroimaging of persistent negative symptoms of schizophrenia.Measuring negative symptom change in schizophrenia: considering alternatives to self-report.Thinking and acting beyond the positive: the role of the cognitive and negative symptoms in schizophrenia.Psychometric evaluation of the negative syndrome of schizophrenia.Probability and magnitude evaluation in schizophrenia.Conceptualization and treatment of negative symptoms in schizophrenia.A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.Quantitative assessment of structural image quality.The aprosody of schizophrenia: Computationally derived acoustic phonetic underpinnings of monotone speech.Is there an optimal factor structure of the Positive and Negative Syndrome Scale in patients with first-episode psychosis?The Concept of Schizophrenia: From Unity to Diversity
P2860
Q27319903-7569D834-7FF8-4ECF-A5EC-CB4F0C743138Q27319966-038A8807-2AA3-42DB-8622-8C89C8A17FA1Q33804836-F43F5164-70F8-4629-9AA9-6B1C15D3201FQ34604423-D94E68E6-DBEC-4544-A654-A4B8EA1FD86EQ35053407-F959D66B-CB46-40E7-87DE-0EB24F470337Q35166963-1AC6AC56-1CBC-4AAD-BBEB-02BD4E250654Q35380728-16A9BAB2-11E1-4607-A9E7-EE3969AE086BQ35754102-F7215602-CD24-4369-9C76-D23D2A94C877Q35794290-2EE43E60-4509-4FF0-B65E-78BBD1D949D4Q36201440-0A187A18-5068-43DE-8BC4-F9253BF2AB38Q36412864-B48CD898-3FA4-4FD2-A58A-A9C276527340Q36602587-3544BB63-ABE5-4398-AE7D-5197DA080C2EQ36908425-1C80ED9D-3918-4416-AB21-20C0448354D2Q37374981-77AE164A-2788-44E0-B9F0-A8C5FD43FEB0Q37479158-DA785119-C508-4B17-AEDD-E7B25F3028E4Q37687029-49481EA0-577A-4FCA-BCC7-A24652C15A2EQ37918714-18DDD2E0-5CD2-4051-AFC4-4B2261BE9443Q37975551-991C6071-068A-4829-81A3-A770DC04912FQ38224360-0EEE0143-77F8-4D0B-9EF4-8FB05FA849E7Q38268878-F5A5DA38-6319-4502-8E52-246F04469589Q38388526-7A746558-9FF0-4D9F-9CBD-F5E5F29D86F6Q38652323-67A57AF3-B8F8-4ED6-A9BA-7E488B6F998EQ39178474-07AA2417-5985-4A38-AB19-866393962676Q42650165-ED2E039A-4D59-4677-8BF3-758A38383117Q47218527-02D4C30F-0D52-438D-9331-35F415927999Q49962407-5AC48D89-1315-48C1-B2E1-57E2D3621F9DQ57741701-70C84FF7-8B0F-489C-97F6-267924C1A24AQ59052397-82F46599-A52E-4DA4-8CA2-3086B67EF3FF
P2860
Initial development and preliminary validation of a new negative symptom measure: the Clinical Assessment Interview for Negative Symptoms (CAINS).
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Initial development and prelim ...... for Negative Symptoms (CAINS).
@ast
Initial development and prelim ...... for Negative Symptoms (CAINS).
@en
Initial development and prelim ...... nterview for Negative Symptoms
@nl
type
label
Initial development and prelim ...... for Negative Symptoms (CAINS).
@ast
Initial development and prelim ...... for Negative Symptoms (CAINS).
@en
Initial development and prelim ...... nterview for Negative Symptoms
@nl
prefLabel
Initial development and prelim ...... for Negative Symptoms (CAINS).
@ast
Initial development and prelim ...... for Negative Symptoms (CAINS).
@en
Initial development and prelim ...... nterview for Negative Symptoms
@nl
P2093
P2860
P1476
Initial development and prelim ...... for Negative Symptoms (CAINS).
@en
P2093
Courtney Forbes
Jack J Blanchard
Melanie Bennett
William P Horan
P2860
P356
10.1016/J.SCHRES.2010.08.039
P407
P50
P577
2010-09-24T00:00:00Z